OBJECTIVE: To identify novel combinations of genetic and psychological factors that predicted 12-month postoperative pain and disability outcomes following arthroscopic shoulder surgery. METHODS: A prospective presurgical cohort (n = 150) was recruited to complete validated psychological questionnaires and have their DNA collected from saliva. DNA was genotyped for a priori selected genes involved with pain modulation (ADRB2, OPRM1, AVPR1A, GCH1, and KCNS1) and inflammation (IL1B, TNF/LTA, and IL6). The outcome measures of interest were the Brief Pain Inventory and Disabilities of the Arm, Shoulder, and Hand questionnaire. Followup for the cohort was at 3, 6, and 12 months postoperatively. After controlling for age, sex, race, and preoperative status, genetic and psychological factors were entered as main effects and interaction terms in separate general linear models for predicting postoperative pain and disability outcomes. RESULTS: Seven interactions involving pain-modulatory genes were identified. Three provided strong statistical evidence for different outcomes, including KCNS1 and kinesiophobia for preoperative pain intensity, ADRB2 and depressive symptoms for postoperative course, and GCH1 and anxiety symptoms for 12-month pain-intensity outcome. Ten interactions involving inflammatory genes were identified. Three provided strong statistical evidence for the 12-month postoperative course outcome, including 2 different IL6 single-nucleotide polymorphism and pain catastrophizing, and IL6 and depressive symptoms. CONCLUSION: The current study identified novel genetic and psychological interactions that can be used in future studies to further understand the development of persistent postoperative pain and investigate the effectiveness of tailored treatment.
OBJECTIVE: To identify novel combinations of genetic and psychological factors that predicted 12-month postoperative pain and disability outcomes following arthroscopic shoulder surgery. METHODS: A prospective presurgical cohort (n = 150) was recruited to complete validated psychological questionnaires and have their DNA collected from saliva. DNA was genotyped for a priori selected genes involved with pain modulation (ADRB2, OPRM1, AVPR1A, GCH1, and KCNS1) and inflammation (IL1B, TNF/LTA, and IL6). The outcome measures of interest were the Brief Pain Inventory and Disabilities of the Arm, Shoulder, and Hand questionnaire. Followup for the cohort was at 3, 6, and 12 months postoperatively. After controlling for age, sex, race, and preoperative status, genetic and psychological factors were entered as main effects and interaction terms in separate general linear models for predicting postoperative pain and disability outcomes. RESULTS: Seven interactions involving pain-modulatory genes were identified. Three provided strong statistical evidence for different outcomes, including KCNS1 and kinesiophobia for preoperative pain intensity, ADRB2 and depressive symptoms for postoperative course, and GCH1 and anxiety symptoms for 12-month pain-intensity outcome. Ten interactions involving inflammatory genes were identified. Three provided strong statistical evidence for the 12-month postoperative course outcome, including 2 different IL6 single-nucleotide polymorphism and pain catastrophizing, and IL6 and depressive symptoms. CONCLUSION: The current study identified novel genetic and psychological interactions that can be used in future studies to further understand the development of persistent postoperative pain and investigate the effectiveness of tailored treatment.
Authors: Michael Costigan; Inna Belfer; Robert S Griffin; Feng Dai; Lee B Barrett; Giovanni Coppola; Tianxia Wu; Carly Kiselycznyk; Minakshi Poddar; Yan Lu; Luda Diatchenko; Shad Smith; Enrique J Cobos; Dmitri Zaykin; Andrew Allchorne; Edith Gershon; Jessica Livneh; Pei-Hong Shen; Lone Nikolajsen; Jaro Karppinen; Minna Männikkö; Anthi Kelempisioti; David Goldman; William Maixner; Daniel H Geschwind; Mitchell B Max; Ze'ev Seltzer; Clifford J Woolf Journal: Brain Date: 2010-08-18 Impact factor: 13.501
Authors: Irmgard Tegeder; Michael Costigan; Robert S Griffin; Andrea Abele; Inna Belfer; Helmut Schmidt; Corina Ehnert; Jemiel Nejim; Claudiu Marian; Joachim Scholz; Tianxia Wu; Andrew Allchorne; Luda Diatchenko; Alexander M Binshtok; David Goldman; Jan Adolph; Swetha Sama; Steven J Atlas; William A Carlezon; Aram Parsegian; Jörn Lötsch; Roger B Fillingim; William Maixner; Gerd Geisslinger; Mitchell B Max; Clifford J Woolf Journal: Nat Med Date: 2006-10-22 Impact factor: 53.440
Authors: Lynne J Hocking; Blair H Smith; Gareth T Jones; David M Reid; David P Strachan; Gary J Macfarlane Journal: Pain Date: 2010-02-18 Impact factor: 6.961
Authors: San Keller; Carla M Bann; Sheri L Dodd; Jeff Schein; Tito R Mendoza; Charles S Cleeland Journal: Clin J Pain Date: 2004 Sep-Oct Impact factor: 3.442
Authors: Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett Journal: Hum Genet Date: 2009-02-01 Impact factor: 4.132
Authors: Steven Z George; Jeffrey J Parr; Margaret R Wallace; Samuel S Wu; Paul A Borsa; Yunfeng Dai; Roger B Fillingim Journal: J Pain Date: 2013-10-05 Impact factor: 5.820
Authors: Rogelio A Coronado; Amee L Seitz; Erica Pelote; Kristin R Archer; Nitin B Jain Journal: Clin Orthop Relat Res Date: 2018-04 Impact factor: 4.176
Authors: Rinco C T Koorevaar; Esther van 't Riet; Marleen J J Gerritsen; Kim Madden; Sjoerd K Bulstra Journal: PLoS One Date: 2016-11-15 Impact factor: 3.240
Authors: Keesha L Powell-Roach; Yingwei Yao; Ellie H Jhun; Ying He; Marie L Suarez; Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Diana J Wilkie Journal: PLoS One Date: 2019-11-11 Impact factor: 3.240